Your browser doesn't support javascript.
loading
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Barnes, Eleanor; Goodyear, Carl S; Willicombe, Michelle; Gaskell, Charlotte; Siebert, Stefan; I de Silva, Thushan; Murray, Sam M; Rea, Daniel; Snowden, John A; Carroll, Miles; Pirrie, Sarah; Bowden, Sarah J; Dunachie, Susanna J; Richter, Alex; Lim, Zixiang; Satsangi, Jack; Cook, Gordon; Pope, Ann; Hughes, Ana; Harrison, Molly; Lim, Sean H; Miller, Paul; Klenerman, Paul; Basu, Neil; Gilmour, Ashley; Irwin, Sophie; Meacham, Georgina; Marjot, Thomas; Dimitriadis, Stavros; Kelleher, Peter; Prendecki, Maria; Clarke, Candice; Mortimer, Paige; McIntyre, Stacey; Selby, Rachael; Meardon, Naomi; Nguyen, Dung; Tipton, Tom; Longet, Stephanie; Laidlaw, Stephen; Orchard, Kim; Ireland, Georgina; Thomas, David; Kearns, Pamela; Kirkham, Amanda; McInnes, Iain B.
Afiliación
  • Barnes E; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Goodyear CS; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Willicombe M; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
  • Gaskell C; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
  • Siebert S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • I de Silva T; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
  • Murray SM; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK.
  • Rea D; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Snowden JA; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Carroll M; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Pirrie S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Bowden SJ; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Dunachie SJ; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Richter A; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Lim Z; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Satsangi J; Clinical Immunology Service, University of Birmingham, Edgbaston, Birmingham, UK.
  • Cook G; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Pope A; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Hughes A; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK.
  • Harrison M; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Lim SH; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Miller P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.
  • Klenerman P; Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Basu N; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gilmour A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Meacham G; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
  • Marjot T; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
  • Dimitriadis S; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Kelleher P; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Prendecki M; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Clarke C; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Mortimer P; Department of Infectious Diseases, Imperial College London, School of Medicine Chelsea and Westminster Hospital, London, UK.
  • McIntyre S; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
  • Selby R; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
  • Meardon N; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
  • Nguyen D; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
  • Tipton T; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
  • Longet S; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK.
  • Laidlaw S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Orchard K; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Ireland G; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Thomas D; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Kearns P; UK Health Security Agency (UKHSA), Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK.
  • McInnes IB; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK.
Nat Med ; 29(7): 1760-1774, 2023 07.
Article en En | MEDLINE | ID: mdl-37414897
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos